About Emprocell Clinical Research Private Limited
Data last updated:
Emprocell Clinical Research Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 24 April 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24231MH2006PTC161334. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.61 Cr. It was formerly known as Em Pro Cell Research Private Limited. It is led by directors including Vasily Babiy and Svetlana Babiy.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Navi Mumbai, Maharashtra.
As per the financials filed for FY 2020, the company reported a revenue of ₹49.13 Lakh, a decline of 51% compared to the previous year. For the same year it recorded a net loss of ₹77.75 Lakh (net margin -158.2%) and EBITDA of -₹36.92 Lakh (EBITDA margin -75.1%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years and 10% over five years.
The company has about 5 employees on its provident fund (EPFO) records.
Court records list 13 cases involving the company, including 1 filed by the company and 12 filed against it; 3 cases are pending.
The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website emprocell.com.
Company details
Contact details
Emprocell Clinical Research Private Limited's registered office is in Navi Mumbai, Maharashtra. Its website is emprocell.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered AddressC – 7/1A Ttc Industrial Area MIDC Village Pawan, E, Navi Mumbai, Maharashtra, India – 400705
- IndustryLife Sciences, Biotechnology
To see the full contact details of Emprocell Clinical Research Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Emprocell Clinical Research is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Emprocell Clinical Research Private Limited, buy the company report.
Financials of Emprocell Clinical Research Private Limited
FY 2020 filings availableEmprocell Clinical Research Private Limited reported revenue of ₹49.13 Lakh (down 51% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 10% over five years, including a 51% fall in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹49.13 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹36.92 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹77.75 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -75.1% | ||||
| Net Profit Margin | -158.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Emprocell Clinical Research Private Limited, buy the company report.
Board of directors of Emprocell Clinical Research Private Limited
Emprocell Clinical Research has 7 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vasily Babiy | Director | 19 Aug 2012 | 14 Years 2 Months | Current |
| Svetlana Babiy | Director | 09 May 2006 | 20 Years 5 Months | Current |
| Viktor Radchenko | Director | 10 Jun 2006 | 20 Years 4 Months | Current |
| Volodymyr Radchenko | Director | 31 Mar 2014 | 12 Years 7 Months | Current |
| Vladimir Evstakhievich Babiy | Director | 09 May 2006 | 20 Years 5 Months | Current |
| Elena Babiy | Director | 09 May 2006 | 20 Years 5 Months | Current |
Auditor
Emprocell Clinical Research Private Limited is audited by S.M. Bhat & Associates for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.M. Bhat & Associates | FY 2020 | 131347W |
Shareholding
The shareholding of Emprocell Clinical Research Private Limited is on record for 2 financial years, the latest being FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Emprocell Clinical Research Private Limited, buy the company report.
Legal cases
Emprocell Clinical Research Private Limited has 13 court cases on record: 1 filed by Emprocell Clinical Research, 12 filed against it. 3 cases are pending and 10 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 7 | 6 | 2 |
| District courts | 6 | 6 | 1 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Appeal | Filed against the company by Lok-Beta Pharmaceuticals (India) Private Limited | Disposed |
| Bombay High Court | Company petition | Filed against the company by Lok-Beta Pharmaceuticals (India) Private Limited | Disposed |
| High Court of Delhi | Court case (RFA(OS)(COMM)) | Filed against the company by an individual | Pending |
| District court, Thane, Maharashtra | Arbitration matter | Filed against the company by an individual | Pending |
| Bombay High Court | Writ petition | Filed against the company | Pending |
To see the full case history of Emprocell Clinical Research Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Emprocell Clinical Research Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Emprocell Clinical Research Private Limited has a workforce of 5 employees on its EPFO records as of Mar 31, 2024, across 1 active EPFO establishment.
GST
Emprocell Clinical Research has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Emprocell Clinical Research Private Limited, buy the company report.
Recent activity
Emprocell Clinical Research Private Limited has 15 board changes on record since 2006: 7 appointments and 8 cessations. The latest: Vyankatesh Jethmal Pidiyar ceased to be Director on 15 Apr 2021.
6 earlier events are in the company report.
Frequently asked questions
Emprocell Clinical Research is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 24 April 2006 (20+ years old) and is registered under CIN U24231MH2006PTC161334.
Emprocell Clinical Research has 7 current directors:
- Vasily Babiy - Director
- Svetlana Babiy - Director
- Viktor Radchenko - Director
- Volodymyr Radchenko - Director
- Vladimir Evstakhievich Babiy - Director
- Elena Babiy - Director
- Oleksandr Kukharchuk - Alternate Director
The latest financial statements of Emprocell Clinical Research on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from 2015 are in the company report.
No. Emprocell Clinical Research has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Emprocell Clinical Research is U24231MH2006PTC161334. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Emprocell Clinical Research has 13 court cases on record: 1 filed by the company and 12 filed against it. 3 are pending. Most are in the high courts.
Emprocell Clinical Research was incorporated on 24 April 2006, making it 20+ years old. It is registered with the Registrar of Companies, Mumbai.
Vyankatesh Jethmal Pidiyar ceased to be Director on 15 Apr 2021. Volodymyr Radchenko ceased to be Additional Director on 16 Dec 2014. Volodymyr Radchenko was appointed as Director on 31 Mar 2014. Emprocell Clinical Research has 15 board changes on record in total.
Emprocell Clinical Research can be reached through the website emprocell.com. Its registered office is in Navi Mumbai, Maharashtra, India.
The registered office of Emprocell Clinical Research is at C – 71A Ttc Industrial Area MIDC Village Pawan, E, Navi Mumbai, Maharashtra, India – 400705.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
